Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 4504612, 8 pages
Review Article

Adipose Tissue-Specialized Immunologic Features Might Be the Potential Therapeutic Target of Prospective Medicines for Obesity

1Department of Pharmacology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China
2School of Nursing, Jilin University, Changchun 130021, China

Correspondence should be addressed to Li Chen

Received 4 January 2017; Revised 3 March 2017; Accepted 13 March 2017; Published 30 March 2017

Academic Editor: Aimin Xu

Copyright © 2017 Fan Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Mengjiao Hao, Zhuoji Guan, Yan Li, Lixian Liu, Xiao Yuan, Ying Gao, and Weimin Li, “The design and synthesis of a novel compound of berberine and baicalein that inhibits the efficacy of lipid accumulation in 3T3-L1 adipocytes,” Bioorganic & Medicinal Chemistry, 2017. View at Publisher · View at Google Scholar
  • Xiao-Qing Xiong, Zhi Geng, Bing Zhou, Feng Zhang, Ying Han, Ye-Bo Zhou, Jue-Jin Wang, Xing-Ya Gao, Qi Chen, Yue-Hua Li, Yu-Ming Kang, and Guo-Qing Zhu, “FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity,” Metabolism, 2018. View at Publisher · View at Google Scholar